2022
DOI: 10.1016/j.jconrel.2022.01.040
|View full text |Cite
|
Sign up to set email alerts
|

Loco-regional radiosensitizing nanoparticles-in-gel augments head and neck cancer chemoradiotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 46 publications
0
10
0
Order By: Relevance
“…Last year, two more publications showed the potential of nanoparticles as radiosensitizers for HNSCC. However, it should be noted that these were not iron oxide nanoparticles and that they were not pure nanoparticles but nanoparticle formulations, so that, in contrast to our study, the radiation-enhancing property cannot be solely attributed to the nanoparticles [ 30 , 31 ].…”
Section: Introductionmentioning
confidence: 60%
“…Last year, two more publications showed the potential of nanoparticles as radiosensitizers for HNSCC. However, it should be noted that these were not iron oxide nanoparticles and that they were not pure nanoparticles but nanoparticle formulations, so that, in contrast to our study, the radiation-enhancing property cannot be solely attributed to the nanoparticles [ 30 , 31 ].…”
Section: Introductionmentioning
confidence: 60%
“…A novel nanocarriers-in-ion-triggered mucoadhesive hydrogel has been prepared to enhance site-specific delivery of clinically relevant radiosensitizers i.e., cisplatin and paclitaxel. The nanoparticles released from hydrogel enhanced the tumor bioaccumulation of chemotherapeutic drugs with reducing systemic absorption, resulting in improvement of efficacy and safety confirmed by PET-CT imaging263 .…”
mentioning
confidence: 89%
“…The nanoparticles released from the hydrogel enhanced the tumor bioaccumulation of chemotherapeutic drugs with reduced systemic absorption, resulting in improvement of efficacy and safety confirmed by PET-CT imaging. 263…”
Section: Treatment Of Head and Neck Squamous Cell Carcinomamentioning
confidence: 99%
“…The hydrogel exhibited sustained tumor bioaccumulation of both anticancer drugs with lower systemic absorption (Figure 8). [276] Tan et al integrated metal-organic frameworks (MOFs) with thermosensitive hydrogel PLGA-PEG-PLGA to generate an injectable system for sustained release of DOX and celecoxib (Cel). The study demonstrated that DOX/Cel/MOFs@Gel had great drug-loading capacity, controlled pH-responsive [276] Copyright 2022, Elsevier.…”
Section: Oral Cancer and Oral Mucosal Diseasesmentioning
confidence: 99%
“…[ 275 ] For in situ tumor therapy, oral mucosal adhesive hydrogels can be applied as a patch or spray, as OSCC develops in the superficial sites of the oral cavity. [ 276 ] Furthermore, smart hydrogels can be developed to respond to different stimuli, such as pH, heat, light, and enzymes, enabling controlled release in the affected site of oral cancer. [ 277 ]…”
Section: Applications In Dental Medicinementioning
confidence: 99%